Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: old 'n cranky who wrote (12539)	12/13/2019 9:16:19 PM
From: old 'n cranky	Respond to of 12873

Looks like the new S-1 will need to be withdrawn, too. I don't think there's enough headroom under the current 7.5M share authorization considering the existing outstanding common, the convertible Preferred A and existing options and warrants. Can't wait to see the terms of the Diwan loan agreement: "Approximately $1 million will be made available immediately upon execution of a definitive agreement and an additional $1 million will be made available in a second tranche in January 2020, or later, at the Company's discretion."